Order Article Reprints

Guberina M, Pöttgen C, Guberina N, Hoffmann C, Wiesweg M, Richlitzki C, Metzenmacher M, Aigner C, Bölükbas S, Gauler T, et al. Long-Term Survival in Patients with Oligometastatic Non-Small Cell Lung Cancer by a Multimodality Treatment—Comparison with Stage III Disease. Cancers. 2024; 16(6):1174. https://doi.org/10.3390/cancers16061174

Guberina, Maja, Christoph Pöttgen, Nika Guberina, Christian Hoffmann, Marcel Wiesweg, Cedric Richlitzki, Martin Metzenmacher, Clemens Aigner, Servet Bölükbas, Thomas Gauler, and et al. 2024. "Long-Term Survival in Patients with Oligometastatic Non-Small Cell Lung Cancer by a Multimodality Treatment—Comparison with Stage III Disease" Cancers 16, no. 6: 1174. https://doi.org/10.3390/cancers16061174

Guberina, M., Pöttgen, C., Guberina, N., Hoffmann, C., Wiesweg, M., Richlitzki, C., Metzenmacher, M., Aigner, C., Bölükbas, S., Gauler, T., Eberhardt, W. E. E., Forsting, M., Herrmann, K., Theegarten, D., Darwiche, K., Jendrossek, V., Stuschke, M., & Schuler, M. (2024). Long-Term Survival in Patients with Oligometastatic Non-Small Cell Lung Cancer by a Multimodality Treatment—Comparison with Stage III Disease. Cancers, 16(6), 1174. https://doi.org/10.3390/cancers16061174